You are here

  • Home
  • Archive
  • Volume 82, Issue 4
  • Response to: ‘Correspondence on ‘Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome’’ by Kawada

Article info

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Correspondence on ‘Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome’’ by Kawada

Authors

  • Silvia Piantoni Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy Rheumatology and Clinical immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy PubMed articlesGoogle scholar articles
  • Laura Andreoli Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy Rheumatology and Clinical immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy PubMed articlesGoogle scholar articles
  • Enrico Colombo Internal Medicine Department, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy COVID Unit, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy PubMed articlesGoogle scholar articles
  • Monia Mendeni Internal Medicine Department, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy COVID Unit, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy PubMed articlesGoogle scholar articles
  • Maria Laura Ghirardelli Internal Medicine Department, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy COVID Unit, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy PubMed articlesGoogle scholar articles
  • Antonio Brucato Università di Milano, Department of Biomedical and Clinical Sciences “Sacco”, Ospedale Fatebenefratelli, Milano, Italy PubMed articlesGoogle scholar articles
  • Massimo Imazio University Cardiology, A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy PubMed articlesGoogle scholar articles
  • Roberto Furloni Internal Medicine Department, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy COVID Unit, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy PubMed articlesGoogle scholar articles
  • Franco Franceschini Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy Rheumatology and Clinical immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy PubMed articlesGoogle scholar articles
  • Paolo Airó Rheumatology and Clinical immunology Unit, ASST Spedali Civili of Brescia, Brescia, Italy PubMed articlesGoogle scholar articles
  • Mirko Scarsi Internal Medicine Department, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy COVID Unit, ASST Valcamonica, Hospital of Esine, Esine (Brescia), Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Silvia Piantoni, Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Brescia, Italy; slv.piantoni{at}gmail.com
View Full Text

Citation

Piantoni S, Andreoli L, Colombo E, et al
Response to: ‘Correspondence on ‘Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome’’ by Kawada
Annals of the Rheumatic Diseases 2023;82:e78.

Publication history

  • Received January 10, 2021
  • Accepted January 12, 2021
  • First published January 27, 2021.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for personal use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage